Irvine, CA (PRWEB) March 13, 2007
Medical Care Corporation (MCC), a California-based healthcare technology company, and three Japanese healthcare service organizations have announced a restructuring of their existing partnership agreements. To more effectively serve new Japanese government wellness initiatives, Saint-Care Corporation, Millennia Corporation, and Imagine Global Care Corporation will collaborate in Japan to speed the adoption of MCC's dementia care products and to efficiently perform wellness assessments on a mass scale.
The longevity of the Japanese population and the rising costs of caring for the elderly have led the Japanese government to develop guidelines for the prevention of dementia. These new guidelines, which include dementia preventative assessments for the elderly, will go into effect beginning in April 2007. Following this campaign, a dementia risk management initiative for younger adults will take effect in April 2008.
One key factor in successfully managing the health of an aging population is the availability of effective tools for assessing cognitive health. "MCC's dementia care products can facilitate prevention, early detection, and management of dementia more effectively than any other available technology. When early stage memory loss is detected, timely intervention can significantly improve treatment efficacy, delay progression of the underlying problem, and improve the patient's quality of life. Doing so is the key to reducing the economic and social burdens of dementing disorders like Alzheimer's disease," says Dennis Fortier, CEO of Medical Care Corporation.
Saint-Care Corporation provides home healthcare services and manages care facilities; Millennia Corporation specializes in home healthcare, hospital management and large-scale data collection; and Imagine Global Care Corporation specializes in prescription drug sales and physician practice business support.
About Medical Care Corporation
Medical Care Corporation develops highly comprehensive dementia care products for healthcare professionals. Their technology enables accurate identification and effective management of memory loss from its earliest stages onward. The company's MCI Screen is 97.3% accurate in distinguishing a pre-dementia stage called mild cognitive impairment (MCI) from normal aging. The company is also a leader in communicating the value of prevention and early detection to patients and caregivers through its website and educational materials. Additional information about the company is available at two websites: For Health Care Providers: http://www.mccare.com; For Patients and Caregivers: http://www.preventad.com